fostimon kit 300 iu inj. sol. (pwdr. + solv.) s.c. pre-filled syr. vial
ibsa farmaceutici italia s.r.l. - urofollitropin 300 iu - powder and solvent for solution for injection - 300 iu - urofollitropin 300 iu/ml - urofollitropin
fostimon kit 225 iu inj. sol. (pwdr. + solv.) s.c. pre-filled syr. vial
ibsa farmaceutici italia s.r.l. - urofollitropin 225 iu - powder and solvent for solution for injection - 225 iu - urofollitropin 225 iu/ml - urofollitropin
inprosub 25 mg inj. sol. s.c./i.m. vial
ibsa farmaceutici italia s.r.l. - progesterone 27,2 mg - solution for injection - 25 mg - progesterone 22.35 mg/ml - progesterone
trimacor 1000 mg soft caps.
ibsa farmaceutici italia s.r.l. - eicosapentaenoic acid 460 mg; docosahexaenoic acid 380 mg; tocopherol-d-alfa 4 mg - capsule, soft - 1000 mg - eicosapentaenoic acid 460 mg; docosahexaenoic acid 380 mg; tocopherol-d-alfa 4 mg - omega-3-triglycerides incl. other esters and acids
flectoflex 140 mg medic. plaster sachet
ibsa farmaceutici italia s.r.l. - diclofenac epolamine 180 mg - eq. diclofenac sodium 140 mg - medicated plaster - 140 mg - diclofenac epolamine 180 mg - diclofenac
diclotopic 1 % gel press. cont.
ibsa farmaceutici italia s.r.l. - diclofenac epolamine 12,93 mg/g - eq. diclofenac 10 mg/g - gel - diclofenac
trimacor 1000 mg soft caps.
ibsa farmaceutici italia s.r.l. - eicosapentaenoic acid 460 mg; docosahexaenoic acid 380 mg; tocopherol-d-alfa 4 mg - capsule, soft - omega-3-triglycerides incl. other esters and acids
fertinorm kit 900 iu inj. sol. (pwdr. + solv.) s.c. pre-filled syr. vial
ibsa farmaceutici italia s.r.l. - menotropine - eq. lutropin alfa 900 iu; menotropine - eq. follicle stimulating hormone (fsh) 900 iu - powder and solvent for solution for injection - human menopausal gonadotrophin
inprosub 25 mg inj. sol. s.c. pre-filled syr.
ibsa farmaceutici italia s.r.l. - progesterone 26,125 mg - solution for injection in pre-filled syringe - progesterone
ialuril procedure pack - bladder instillation, barrier
juno pharmaceuticals pty ltd - 44670 - bladder instillation, barrier - procedure pack consisting of a clear plastic pre-filled syringe containing a sterile aqueous solution of hyaluronic acid sodium salt (1.6%), sodium chondroitin sulphate (2%) and calcium chloride administered as a bladder instillation via connection to a catheter using the leur lock adaptor and the ialuadapter included in the pack. the ialuadapter allows for administration by either the patient or healthcare professional. ialuril is indicated to re-establish the glycosaminoglycan layers (gags) of the urothelial vesical tissue in cases in which their loss can cause frequent and recurring problems such as painful bladder syndrome (pbs), interstitial cystitis, treatment and prevention of recurrent urinary tract infection, cystitis as a result of bacillus calmette ? guerin therapy, or chemical and radiation therapy. ialuril is also indicated in the cases where the loss of the glycosaminoglycan layers (gags) is associated with forms of chronic inflammation, in which their composition and integrity appears compromised in different ways.